CRISPR-guided DNA base editors enable the efficient installation of targeted single-nucleotide changes. Cytosine or adenine base editors (CBEs or ABEs), which are fusions of cytidine or adenosine deaminases to CRISPR-Cas nickases, can efficiently induce DNA C-to-T or A-to-G alterations in DNA, respectively [1] [2] [3] [4] . We recently demonstrated that both the widely used CBE BE3 (harboring a rat APOBEC1 cytidine deaminase) and the optimized ABEmax editor can induce tens of thousands of guide RNA-independent, transcriptome-wide RNA base edits in human cells with high efficiencies 5 . In addition, we showed the feasibility of creating SElective Curbing of Unwanted RNA Editing (SECURE)-BE3 variants that exhibit substantially reduced unwanted RNA editing activities while retaining robust and more precise on-target DNA editing 5 . Here we describe structure-guided engineering of SECURE-ABE variants that not only possess reduced off-target RNA editing with comparable on-target DNA activities but are also the smallest Streptococcus pyogenes Cas9 (SpCas9) base editors described to date. In addition, we tested CBEs composed of cytidine deaminases other than APOBEC1 and found that human APOBEC3A (hA3A) cytidine deaminase CBE induces substantial transcriptome-wide RNA base edits with high efficiencies. By contrast, a previously described "enhanced" A3A (eA3A) cytidine deaminase CBE or a human activation-induced cytidine deaminase (hAID) CBE induce substantially reduced or near background levels of RNA edits. In sum, our work describes broadly useful SECURE-ABE and -CBE base editors and reinforces the importance of minimizing RNA editing activities of DNA base editors for research and therapeutic applications.
Introduction
CRISPR-guided DNA base editor technology has been rapidly adopted for use in a variety of different cell types and organisms 1 . We recently demonstrated that the BE3 CBE and ABEmax can induce transcriptome-wide RNA off-target edits in human cells 5 . We also showed the feasibility of engineering a SECURE version of BE3 5 . Based on these studies, we were interested in exploring whether it might be possible to engineer a SECURE ABE and to define the RNA offtarget profiles of other CBEs bearing cytidine deaminases other than the APOBEC1 enzyme present in BE3.
Results
To attempt to engineer SECURE-ABE variants, we first used a protein truncation strategy to reduce the RNA recognition capability of the widely used ABEmax fusion. ABEmax harbors a single-chain heterodimer of the wild type (WT) E. coli TadA adenosine deaminase monomer (which deaminates adenines on tRNA) fused to an engineered E. coli TadA monomer that was modified by directed evolution to deaminate DNA adenines 3, 6, 7 (Fig. 1a) . We hypothesized that the WT TadA monomer should still be capable of recognizing its tRNA substrate and therefore might recruit ABEmax to deaminate RNA adenines that lie in the same or a similar sequence motif to that present in the tRNA. Consistent with this idea, a re-analysis of our previously published RNA-seq data 5 revealed that adenines that are edited at the highest efficiencies (80-100%) are embedded in a more extended CUACGAA motif, which contrasts to the shorter UA sequence observed across all edits (Fig. 1b) . Importantly, the CUACGAA motif is a perfect match to the sequence surrounding the adenine deaminated in the tRNA substrate of the WT E. coli 4 TadA enzyme 6 . We reasoned that removing the WT TadA domain from ABEmax might reduce its RNA editing activity and we therefore generated a smaller ABEmax variant lacking this domain that we refer to as miniABEmax (Fig. 1a) .
We used RNA-seq to compare the transcriptome-wide off-target RNA editing activities of miniABEmax to ABEmax in HEK293T cells. Both editors and a nickase Cas9 (nCas9) control were each assayed in biological triplicate with three different gRNAs: two targeted to endogenous human gene sites (HEK site 2 and ABE site 16) 3 and one to a site that does not occur in the human genome (NT) 5 . We performed these studies by sorting for GFP-positive cells (ABEmax was expressed as a P2A fusion with the base editor or nCas9 (Methods)). As an internal control, we first confirmed that ABEmax and miniABEmax both induced comparable on-target DNA editing efficiencies with HEK site 2 and ABE site 16 gRNAs (Extended Data Fig. 1 ). Edited RNA adenines were identified as previously described 5 by filtering out background editing observed with read-count-matched negative controls (Methods) . Surprisingly, the total number of edited adenines induced with miniABEmax expression was not consistently lower than what we observed with ABEmax --the two editors induced on average 80-fold and 54-fold more edited adenines relative to background (determined with a GFP-only negative control) ( Fig. 1c and Table 1 ). However, the overall distribution of individual RNA adenine edit efficiencies induced by miniABEmax were generally shifted to lower values ( Fig. 1d and Fig. 2 ). In addition, the sequence logos of the adenines edited by miniABEmax now appear to be shorter GUA or UA motifs, in contrast to the more extended CUACGAA motif characteristic of ABEmax (Extended Data Fig. 3a and 3b) . 5 We reasoned we might further reduce the off-target RNA editing activity of miniABEmax by altering amino acid residues within the remaining engineered E. coli TadA domain that could potentially mediate RNA recognition. However, although a crystal structure of isolated E. coli TadA has previously been solved 8 (PDB 1Z3A; Fig. 1e ), no structural information was available to delineate how this protein might recognize its RNA substrate. To overcome this, we exploited the availability of a S. aureus TadA-tRNA co-crystal structure 9 (PDB 2B3J) ( Fig. 1e and Methods) .
Extended Data

Although E. coli and S. aureus TadA share only partial amino acid sequence homology (39.5% identity; Extended Data Fig. 4a ), we found that these two proteins share a high degree of structural homology (Fig. 1e) . This similarity enabled us to overlay the two structures and thereby to infer 31 amino acid residues in E. coli TadA that likely lie near the enzymatic pocket around the substrate tRNA (Fig. 1e) . In addition, we mutated three positively charged residues (R13, K20, and R21) in TadA* that we imagined might make contacts to the phosphate backbone of an RNA substrate.
We generated a total of 34 miniABEmax variants bearing various substitutions at the amino acid positions described above and screened each editor for on-target DNA editing and off-target RNA editing activities in HEK293T cells. To assess on-target DNA editing, we examined the efficiencies of A-to-G edits induced by each of the 34 variants with four gRNAs targeted to different endogenous gene sequences. To screen for off-target RNA editing activities, we quantified editing by each of the 34 variants at six RNA adenines using standard plasmid expression conditions (i.e., without sorting for GFP expression; see Methods); these six 6 adenines were previously identified as being highly edited with ABEmax overexpression in HEK293T cells 5 . These experiments revealed that 23 of the 34 variants induced robust on-target DNA editing at least comparable to that observed with miniABEmax and ABEmax ( Fig. 1f and Fig. 4b ). In addition, 14 of the 34 variants showed reduced editing activities on at least three of the six RNA adenines we examined relative to that observed with miniABEmax ( Fig. 1f, Extended Data Fig. 4b) . Importantly, three of the 34 variants (miniABEmax-K20A/R21A, -K20A/R21A/R23A, and -V82G) showed both robust on-target DNA editing activity and substantially reduced RNA editing activities ( Fig. 1f and Extended Data Fig. 4b and Extended Data Table 2 ). Based on their DNA/RNA editing ratios, we chose to carry forward two miniABEmax variants (K20A/R21A and V82G) for more comprehensive characterization.
We characterized the transcriptome-wide off-target RNA editing profiles of the miniABEmax K20A/R21A and V82G variants using RNA-seq. The two variants were assessed in biological triplicate with the HEK site 2, ABE site 16, and NT gRNAs. In contrast to what we observed with miniABEmax, the K20A/R21A and V82G variants both induced substantially reduced numbers of edited adenines relative to ABEmax but still approximately four-fold and three-fold higher numbers, respectively, than background (determined with the GFP-only negative control) (Fig.   1c) . In addition, the distribution of individual RNA adenine editing efficiencies for the two variants was shifted lower with both variants relative to ABEmax and miniABEmax ( Fig. 1d and Fig. 2) . Overall, these results demonstrate, as we previously showed with the BE3 CBE, the feasibility of separating unwanted off-target RNA editing from desired on-target DNA editing activities with an ABE.
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Having previously shown that off-target RNA editing occurs with BE3 CBE harboring the APOBEC1 enzyme 5 , we wanted to determine whether CBEs harboring other cytosine deaminases such as hA3A 10 , eA3A 11 (an engineered A3A with more precise and specific DNA editing activities), or hAID 12 might also induce unwanted edits. To do this, we transfected HEK293T cells in biological triplicates with plasmids expressing each of these CBEs and a guide RNA (gRNA) targeting a site in the RNF2 gene. We then sorted cells with high CBE expression (top 5% of GFP signal) for isolation of genomic DNA (for on-target DNA amplicon sequencing) and total RNA (for RNA-seq) (Methods). Consistent with previously published studies 10-12 , hA3A-BE3 and eA3A-BE3 both showed robust on-target DNA editing (means of 91% and 82%, respectively, on position C6) with eA3A-BE3 showing greater precision while hAID-BE3 showed somewhat less efficient on-target DNA editing (mean of 32% on C6) (Fig. 2a) . RNA-seq experiments revealed that hA3A-BE3 induced tens of thousands of C-to-U edits ( Fig. 5 ). This extended motif is consistent with a previous study that characterized RNA cytosines edited by the hA3A enzyme 13 . By contrast, eA3A-BE3
showed a dramatically reduced number of RNA edits relative to hA3A-BE3 but still slightly more Table 1 ). Interestingly, AID-BE3 showed numbers of RNA C-to-U edits comparable to what was observed in the negative control (Fig. 2b, Extended Data Fig. 6 and Extended Data Table 1) , consistent with a previous study that showed overexpression of isolated AID enzyme in activated B cells did not yield evidence for RNA editing 14 .
Discussion
The work described here extends our understanding of the off-target RNA editing activities of DNA base editors, expands the options available to minimize these unwanted effects, and provides novel SECURE base editor architectures with desirable properties. The successful engineering of SECURE-ABE variants shows that, as we previously found with the BE3 CBE 5 , it is possible to minimize unwanted RNA editing while retaining efficient on-target DNA editing for an ABE. In the process of engineering these variants, we discovered a more extended consensus sequence motif for adenines edited with high efficiencies by ABEmax (CUACGAA) that appears to be recognized by the wild-type TadA part of this fusion. Deletion of this TadA domain abolished recognition of these high efficiency sites and also resulted in the generation of the smallest SpCas9 base editors (1605 amino acids in length) described to date. In addition, our characterization of additional CBEs with deaminases other than APOBEC1 further expands the toolbox of base editors that can be used without inducing high-level RNA editing. 
miniABEmax, and SECURE-ABE in HEK293T cells
Histograms showing the total number of RNA A-to-I edits observed (y-axis) for different editing efficiencies (x-axis) for ABEmax, miniABEmax, miniABEmax-K20A/R21A, and miniABEmax-V82G each tested with the ABE site 16, HEK site 2, and NT gRNAs. n= number of modified adenines.
Experiments were performed in biological triplicate (data is derived from the same experiments as Fig. 1c and d aureus TadA with tRNA was superimposed with subunit A of E. coli TadA using the "super" command. All figures were generated with PyMOL (Schrödinger). Supplementary Table 1) were cloned using the backbone and the P2A-EGFP-NLS fragment of ABEmax-P2A-EGFP-NLS (AgeI/NotI digest; Addgene ID 112101). ABEmax and variants were expressed under the control of a pCMV promoter. All CBE constructs were cloned using the backbone of SQT817 and expressed under the control of a pCAG promoter (AgeI-NotI-EcoRV digest, Addgene ID 53373). For the P2A-EGFP fragments in these constructs, we used BPK4335 (pCMV-BE3-P2A-EGFP) as a template. Guide RNA (gRNA) plasmids were cloned using the SpCas9 gRNA entry vector BPK1520 (pUC19 backbone; BsmbI cassette, Addgene ID 65777). All remaining constructs were generated using isothermal amplification (Gibson assembly, NEB). All gRNA and ABE plasmids were midi or maxi prepped using the Qiagen Midi/Maxi Plus kits. Library preparation for DNA or cDNA targeted amplicon sequencing. Next-generation sequencing (NGS) of DNA or cDNA was performed as previously described 5 . In summary, the first PCR was performed to amplify genomic or transcriptomic sites of interested with primers containing Illumina forward and reverse adapter sequences (see Supplementary Table 2 showing ABE and CBE on-target DNA editing ( Fig. 2 and Extended Data Fig. 1) show an editing window that includes the edited Cs and a grey background for editing efficiencies smaller than 2%. Tables with the full output will be made available as Supplementary Materials.
Plasmid cloning. All ABE constructs (reported in
RNA variant calling pipeline
All bioinformatic analysis was performed in concordance with GATK Best Practices 18,19 for RNAseq mutation calling as we have previously described 5 . Briefly, raw sequencing reads were twopass aligned to the reference hg38 reference genome with STAR 20 with parameters to discard multi-mapping reads. After PCR duplicate removal and base recalibration, mutations in RNA-seq libraries were called using GATK HaplotypeCaller. RNA edits in CBE and ABE overexpression 19 experiments were identified using a downstream modification of the GATK pipeline output as we have previously described 5 . Specifically, mutation positions called by HaplotypeCaller were further filtered to include only those satisfying the following criteria with reference to the corresponding control experiments: (1) Read coverage for a given edit in control experiment should be greater than the 90th percentile of read coverage across all edits in the overexpression experiment. (2) 99% of reads covering each edit in the control experiment were required to contain the reference allele. Edits were further filtered to exclude those with fewer than 10 reads or 0% alternate allele frequencies. A-G edits include A-G edits identified on the positive strand as well as T-C edits identified on the negative strand. For CBE overexpression experiments, C-T edits include C-T edits identified on the positive strand as well as G-A edits derived from the negative strand.
Six A-to-I edits identified from the above pipeline were chosen to test SECURE ABE variants based on the following criteria. These were sites that had (1) read coverage of at least 50 in all replicates of control and overexpression experiments, (2) 99% reads in all control experiments containing reference allele and (3) at least 60% alternate allele frequencies in all replicates.
From this list, primers were tested for the top 15 edited sites that were also within 150 bases of an exon-exon junction and the 6 highest edited sites with robust amplification from cDNA were chosen. 
